3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Sleep Wake Disorders
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Tobacco Smoking
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Depression
1
Interventions
Tamoxifen
6
Radiotherapy
3
Anastrozole
3
Taxes
2
Simvastatin
2
Radiation
2
Paclitaxel
2
Neoadjuvant Therapy
2
Letrozole
2
Gene Expression Profiling
2
Chemotherapy, Adjuvant
2
Celecoxib
2
telapristone acetate
1
poly(I).poly(c12,U)
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Yoga
1
Sugars
1
Sentinel Lymph Node Biopsy
1
Ranitidine
1
Radiation Dose Hypofractionation
1
Pharmacogenomic Testing
1
Naltrexone
1
Monitoring, Physiologic
1
Mometasone Furoate
1
Metformin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Breast Carcinoma In Situ
×
Counseling
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts